"Study Of Guggul Vatika And Kaishor Guggul In Vatarakta"

"Randomized Control Clinical Trial Of Efficacy Of Guggul Vatika In Vatarakta"

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/10/037157

Enrollment

Registered

2021-10-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified Health Condition 2: M100- Idiopathic gout

Interventions

Intervention1: Guggul vatika 500 mg BD: Guggul Vatika 500 mg BD Orally with Honey for 21 Days Control Intervention1: Kaishor guggul 500 mg BD: Kaishor Guggul 500mg BD Orally With lukewarm water For 21

Eligibility

Inclusion criteria

Inclusion criteria: Patient with Classical Signs And Symptoms Of Vatarakta ,Sandhishul,Daha,sandhishotha, Sparshasahatva,aaraktavarnata. hyperuricemia(above 6.8 mg/dl to 10.0) with symptoms of gout.

Exclusion criteria

Exclusion criteria: Patients associated with Metabolic disorders and other systemic. patient with autoimmune disease. Patient who are on regular NSAIDS and Steroidal anti-inflammatory drug

Design outcomes

Primary

Measure	Time frame
To study efficacy of Kaishor guggul and Guggul Vatika in VataraktaTimepoint: 18 months	—

Secondary

Measure	Time frame
Characteristic of Guggul vatika and Kaishor Guggul in VataraktaTimepoint: 18 months	—

Countries

India

Contacts

Public ContactSnehal shivaji kamble

Hon Shri Annasaheb Dange Ayurvedic Medical College And Research Centre Ashta

drdattatryanikam@gmail.com8390761674

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026